- Home
- PRT vs OKYO Comparison
PRT vs OKYO Comparison
Compare PRT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRT
- OKYO
- Stock Information
- Founded
- PRT 2017
- OKYO 2007
- Country
- PRT United States
- OKYO United Kingdom
- Employees
- PRT N/A
- OKYO N/A
- Industry
- PRT Oil & Gas Production
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRT Energy
- OKYO Health Care
- Exchange
- PRT Nasdaq
- OKYO Nasdaq
- Market Cap
- PRT 45.9M
- OKYO 38.2M
- IPO Year
- PRT N/A
- OKYO 2022
- Fundamental
- Price
- PRT $3.95
- OKYO $1.07
- Analyst Decision
- PRT
- OKYO Strong Buy
- Analyst Count
- PRT 0
- OKYO 1
- Target Price
- PRT N/A
- OKYO $7.00
- AVG Volume (30 Days)
- PRT 55.1K
- OKYO 131.4K
- Earning Date
- PRT 11-29-2024
- OKYO 11-22-2024
- Dividend Yield
- PRT 9.11%
- OKYO N/A
- EPS Growth
- PRT N/A
- OKYO N/A
- EPS
- PRT 0.44
- OKYO N/A
- Revenue
- PRT $6,201,668.00
- OKYO N/A
- Revenue This Year
- PRT N/A
- OKYO N/A
- Revenue Next Year
- PRT N/A
- OKYO N/A
- P/E Ratio
- PRT $9.08
- OKYO N/A
- Revenue Growth
- PRT N/A
- OKYO N/A
- 52 Week Low
- PRT $3.58
- OKYO $0.81
- 52 Week High
- PRT $5.18
- OKYO $2.12
- Technical
- Relative Strength Index (RSI)
- PRT 51.97
- OKYO 46.47
- Support Level
- PRT $3.81
- OKYO $1.07
- Resistance Level
- PRT $4.00
- OKYO $1.30
- Average True Range (ATR)
- PRT 0.12
- OKYO 0.07
- MACD
- PRT 0.01
- OKYO -0.01
- Stochastic Oscillator
- PRT 62.22
- OKYO 9.62
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.